Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Chattem

This article was originally published in The Tan Sheet

Executive Summary

Chattem: U.S. sales increase 6% in fiscal 1995 (ended Nov. 30), led by the recently acquired pHisoderm skin care and Benzodent denture analgesic brands; a "significant gain" in Bullfrog sunscreens; and "strong demand" for Icy Hot analgesics, the firm says Jan. 26. Pamprin and Premsyn PMS menstrual products were flat and Flex-all analgesic sales were down. Chattem's international sales 14% jump was driven by pHisoderm in Canada and all major brands in Europe, the firm says. Consolidated sales rose 6.6% to $100.7 mil. in fiscal 1995. Net income was $12 mil., up from $2.1 mil. in FY 1994, and includes a $9.3 mil. gain from the disposal of the Specialty Chemicals division in May 1995. Income from operations increased 15.4% to $14.5 mil...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084721

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel